1-(9-(4-chlorophenyl)-8-(2-chlorophenyl)-9H-purin-6-yl)-4-ethylaminopiperidine-4-carboxylic acid amide,
CP 945598,
CP-945598,
CP945598,
Otenabant hydrochloride,
686347-12-6,
CP 945598 Hydrochloride,
Otenabant (Hydrochloride),
CP-945598 HCl,
CP-945598,
Otenabant HCl,
UNII-X2166Z319O,
CP945598 Hydrochloride,
CP-945598 Hydrochloride,
Otenabant hydrochloride (USAN),
Otenabant hydrochloride [USAN],
Otenabant (CP-945598) HCl,
X2166Z319O,
1-(8-(2-chlorophenyl)-9-(4-chlorophenyl)-9H-purin-6-yl)-4-(ethylamino)piperidine-4-carboxamide hydrochloride,
1-[8-(2-Chlorophenyl)-9-(4-chlorophenyl)-9H-purin-6-yl]-4-(ethylamino)piperidine-4-carboxamide hydrochloride,
CP 945598-01,
cp-945598-hcl,
C25H26Cl3N7O,
Cp945598.HCl,
Otenabant(CP945598.HCl),
SCHEMBL3932007,
CHEMBL2103817,
CP945598HCL,
KS-00000XID,
EX-A142,
BCP06883,
HY-10871A,
MFCD18251544,
s8012,
AKOS024458047,
API0010252,
CS-1278,
SB16484,
1-(8-(2-Chlorophenyl)-9-(4-chlorophenyl)-9H-purin-6-yl)-4-(ethylamino)piperidine-4-carboxamide monohydrochloride,
919516-56-6,
BC600513,
DA-41691,
AB0035918,
FT-0665219,
Y0367,
(-)-CP 55940,
A11942,
D09363,
S-7772,
(1|A,2|A,5|A)-(-)-5-(1,1-Dimethylheptyl)-2-[5-hydroxy-2-(3-hydroxypropyl)cyclohexyl]phenol,
1-[8-(2-Chlorophenyl)-9-(4-chloroph??enyl)-9H-purin-6-yl]-4-(ethylamino)piperidine-4-ca??rboxamide hydrochloride,
4-Piperidinecarboxamide,1-[8-(2-chlorophenyl)-9-(4-chlorophenyl)-9H-purin-6-yl]-4-(ethylamino)-,hydrochloride,
otenabant,
Otenabant (USAN/INN),
D0J0AE,
cc-658,
CP 945598,
CP-945,598,
CP 55940,
CP945598,
CP 55,940,
A1435,
686347-12-6 (HCl),
(-)-cis-3-[2-Hydroxy-4-(1,1-dimethylheptyl)phenyl]-trans-4-(3-hydroxypropyl)cyclohexanol,
1-[8-(2-chlorophenyl)-9-(4-chlorophenyl)purin-6-yl]-4-ethylamino-piperidine-4-carboxamide,
5-(1,1-Dimethylheptyl)-2-[(1R,2R,5R)-5-hydroxy-2-(3-hydroxypropyl)cyclohexyl]phenol,
677010-34-3,
686344-29-6,
83002-04-4,